PYRAZOLSULFONAMIDE ALS ANTITUMORMITTEL
European patent · EP3953331 · Deleted
Register entry
- Publication number
- EP3953331
- Application number
- EP20788312
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Apr 6, 2020
- Published
- Feb 16, 2022
- Granted
- Nov 20, 2024
- Deleted
- Nov 25, 2025
- Reason
- Annual fee unpaid
- IPC classes
- C07D 401/14 (2006.01)C07D 403/12 (2006.01)C07D 403/14 (2006.01)C07D 405/14 (2006.01)C07D 409/14 (2006.01)A61K 31/416 (2006.01)A61P 35/00 (2006.01)
- Priority
- US 201962832125 P 10.04.2019
- PCT application
- PCT/US2020/026799 06.04.2020
- PCT publication
- WO2020/210139 15.10.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 25, 2025
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 25.11.2025
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 25.11.2025
- Sep 24, 2025
Change
Published in Swissreg on 24.09.2025
- Nov 20, 2024
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 20.11.2024
Parties
Inventor
ESTRADA, Michelle Ann
Dallas, Texas 75235-7323, US
GRINA, Jonas
Dallas, Texas 75235-7323, US
WEHN, Paul
Dallas, Texas 75235-7323, US
XU, Rui
Dallas, Texas 75235-7323, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.